Psoriasis Trial, Recruiting NCT06574178 Sponsor: University of California, Davis Condition: Psoriasis
Back to Psoriasis

Psoriasis Trial, Recruiting

NCT06574178
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults over 18 years old, of any sex
  • People who have a history of psoriasis affecting at least 3% of their body surface area, and who are willing to allow the lead researcher to perform skin biopsies on an affected area (this part is optional)
  • People who also have a diagnosis of psoriatic arthritis may be eligible as well
  • People with a Body Mass Index (BMI) of 25 or higher (which is considered overweight or above)
  • People who are able to go without food or drink for at least 6 hours before and during a scan visit
  • People who are able to avoid intense physical exercise for 24 hours before being scanned
  • People whose usual diet is assessed as unhealthy, based on a food questionnaire and a three-day food diary — a scoring system will be used, and only those with a score below 58 (indicating a poor diet) will meet this part of the criteria

Who may not be able to join:

  • People who take oral or injected medications to manage diabetes
  • People who are already following a diet that restricts calories or specific food components
  • People who follow a vegan or vegetarian diet, or who have a food allergy or intolerance to ingredients used in the study diet
  • People whose body weight has changed by more than 5% in the past 2 months
  • People who have taken any whole-body (systemic) medications to treat psoriasis or psoriatic arthritis within 3 months before the first scan, or who would need to take such medications during the trial
  • People who have reported a fear of enclosed spaces (claustrophobia) or discomfort in closed environments
  • People with poorly controlled diabetes, or whose blood sugar level is above 180 mg/dl at the time of the scan injection
  • People who weigh more than 240 kg, due to the weight limit of the scanning equipment
  • People with a known inflammatory condition or active infection that could affect the study results
  • People who are pregnant or breastfeeding — a urine pregnancy test will be given before each scan session to participants who are able to become pregnant and are between 18 and 60 years old, unless documented surgical removal of the uterus or both ovaries is on record, due to risks from the radiation used in the scan
  • People who are unable to lie still on a scanner bed with their arms at their sides for up to 60 minutes
  • People who are currently taking part in another research study that may conflict with this one, or who have had a PET scan as part of a research study within the last 12 months
  • People who are not willing to sign a consent form agreeing to take part
  • People who are unable to understand the risks and benefits of the study
  • People who are currently incarcerated

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Samuel T Hwang, MD, PhD, UC Davis SOM Department of Dermatology

Phone: 9165512636

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Inflammation in PET/CT scan

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov